View Older Stories View More Recent Stories

Nov 27, 2024 09:18AM TD Cowen Reiterates Buy Rating on Amgen (AMGN)
Nov 27, 2024 06:19AM Amgen (AMGN) PT Raised to $352 at Leerink Partners
Nov 27, 2024 05:02AM Increasing unusual put option volume: EDR JWN FXY TKO BHC MXEF RCAT URBN NOK ACHR SATS AMGN
Nov 26, 2024 02:41PM Oppenheimer Reiterates Outperform Rating on Amgen (AMGN), 'the totality of MariTide's data is still competitive'
Nov 26, 2024 01:17PM BTIG Reiterates Viking Therapeutic (VKTX) at Buy, 'continue to see sub-q VK2735 remaining highly competitive'
Nov 26, 2024 10:37AM Piper Sandler Reiterates Overweight Rating on Amgen (AMGN)
Nov 26, 2024 10:26AM Increasing unusual call option volume: KULR RGTI MSTZ NNE QBTS PL DKS SJM VUZI ARQT KODK SIGA SMTC WSM RDW HST AMGN BLBD
Nov 26, 2024 07:58AM Morgan Stanley on Amgen (AMGN): 'Initial thoughts on Maritide Ph2 diabesity data'
Nov 26, 2024 07:11AM Amgen (AMGN) Falls 8% Following Obesity Data, Rivals Lilly (LLY), Novo Nordisk (NVO) Gain 4%
Nov 26, 2024 07:05AM Amgen (AMGN) Announces Robust Weight Loss With Maritide In People Living With Obesity Or Overweight At 52 Weeks In A Phase 2 Study
Nov 20, 2024 04:01PM Amgen (AMGN) Appoints Howard Chang as SVP of Research
Nov 18, 2024 02:10PM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
Nov 13, 2024 04:07PM Citi Starts Amgen (AMGN) at Neutral
Nov 13, 2024 11:12AM TD Cowen Reiterates Buy Rating on Amgen (AMGN)
Nov 13, 2024 06:25AM Amgen (AMGN) Issues Statement on MariTide Phase 1 data
Nov 13, 2024 04:34AM Amgen (AMGN) call put ratio 1 call to 1 put after Amgen's AMG-133 Phase 1 bone data
Nov 12, 2024 04:24PM BMO Capital Reiterates Outperform Rating on Amgen (AMGN)
Nov 12, 2024 04:23PM Barclays Reiterates Equalweight Rating on Amgen (AMGN)
Nov 12, 2024 03:44PM Jefferies on Amgen (AMGN): 'Thoughts on Phase I bone data for AMG-133 - seems non-issue'
Nov 12, 2024 02:48PM Cantor Fitzgerald Locates Data on Amgen (AMGN) Hidden in Tables for MariTide's Data
Nov 12, 2024 02:30PM Amgen (AMGN) Quickly Falls to Low, Down Over 4% on Obesity Data Concerns
Nov 8, 2024 07:06AM Amgen (AMGN): Tezspire Met Both Co-primary Endpoints In Phase 3 Trial For Chronic Rhinosinusitis With Nasal Polyps
Oct 30, 2024 04:02PM Amgen (AMGN) Tops Q3 EPS by 47c; offers guidance
Oct 30, 2024 10:57AM Amgen (AMGN) November 1 weekly option implied volatility into quarter results
Oct 29, 2024 11:21AM Amgen (AMGN) option IV at high end of range into quarter results
Oct 25, 2024 04:01PM Amgen (AMGN) Declares $2.25 Quarterly Dividend; 2.8% Yield
Oct 22, 2024 03:26PM Amgen (AMGN) Launches Pavblu As Rival To Regeneron's (REGN) Eylea - Bloomberg
Oct 21, 2024 08:24AM Amgen (AMGN) PT Raised to $383 at TD Cowen
Oct 16, 2024 06:02AM Goldman Sachs Reiterates Conviction Buy Rating on Amgen (AMGN)
Oct 15, 2024 02:20PM TD Cowen Reiterates Buy Rating on Amgen (AMGN)
Oct 15, 2024 08:01AM Amgen (AMGN) presents positive top-line results from the Phase 3 MINT trial
Oct 14, 2024 06:05AM Truist Securities Downgrades Amgen (AMGN) to Hold
Sep 25, 2024 03:12PM Amgen (AMGN) October 350 and 360 calls active as share price down 5.3%
Sep 25, 2024 08:22AM Goldman Sachs Reiterates Buy Rating on Immunovant (IMVT)
Sep 25, 2024 07:35AM TD Cowen Reiterates Buy Rating on Amgen (AMGN)
Sep 25, 2024 07:23AM BMO Capital Reiterates Outperform Rating on Amgen (AMGN)
Sep 25, 2024 07:14AM Piper Sandler Reiterates Overweight Rating on Amgen (AMGN)
Sep 25, 2024 06:49AM Baird Reiterates Underperform Rating on Amgen (AMGN)
Sep 25, 2024 05:43AM Truist Securities Reiterates Buy Rating on Amgen (AMGN)
Sep 24, 2024 04:00PM Amgen (AMGN) Tepezza Receives Approval In Japan For The Treatment Of Active Thyroid Eye Disease
Sep 23, 2024 04:01PM Amgen (AMGN) To Host Conference Call To Discuss New Topline Data In Inflammation And Rare Disease
Sep 17, 2024 06:03AM Oppenheimer Reiterates Outperform Rating on Amgen (AMGN)
Aug 20, 2024 09:01AM Amgen (AMGN): Otezla Now Available In The U.S. For Moderate To Severe Pediatric Plaque Psoriasis
Aug 15, 2024 09:20AM TD Cowen Reiterates Buy Rating on Amgen (AMGN)
Aug 7, 2024 12:28PM Midday movers: Super Micro Computer, Airbnb and Lyft fall; Shopify rises
Aug 7, 2024 10:09AM Amgen (AMGN) PT Raised to $381 at TD Cowen
Aug 7, 2024 06:26AM Amgen (AMGN) PT Raised to $362 at RBC Capital
Aug 7, 2024 05:03AM Stocks expected to have increasing option volume: AMGN ABNB FTNT SMCI RIVN TOST RDDT WYNN VFC CRUS IAC TRIP
Aug 7, 2024 04:34AM Wells Fargo Downgrades Amgen (AMGN) to Equal Weight
Aug 6, 2024 04:03PM Amgen (AMGN) Misses Q2 EPS by 1c; updates guidance
View More Recent Stories View Older Stories